Year-In-Review Report (2018-2019): External Portfolio


Written by:
Douglas Doucette

As President and External Liaison from 2018-2019, I would like to reflect on several exciting events that took place during this time in our Society, including several “firsts”.

After over 15 years at the helm of CSHP, Myrella Roy retired as our Executive Director in December of 2018. Myrella will be remembered for her dedicated and consistent leadership, always showing her passion for our profession. We wish her a happy and healthy retirement!

Shortly after our Fall Board Meeting and AGM held in October of 2018 in Winnipeg, it was announced that Jody Ciufo would be our first Chief Executive Officer following Myrella’s retirement. Jody won over the Board with her extensive experience in association management and record of success in making bold changes in past executive roles. I accompanied Jody on visits to several hospitals and committee meetings, where I witnessed how keen she is to learn about hospital pharmacy and meet our members, supporters, sponsors and external stakeholders. I am confident that our Board made an ideal choice for the future of CSHP.

Much of my presidential year was occupied with leading the planning and consultation of re-establishing CSHP as a stronger member-centric professional association. The Board worked diligently and collaboratively to develop the CSHP Strategy Towards Sustainability, designed to increase the value of our programs and services for members, and to regain a solid financial foundation. This has been made possible in large part due to the willingness of all branches to co-invest in the plan. In the spirit of ‘doing things differently’ to get different results, I appeared in videos to inform members of our Strategy, as well as to announce our 2019 National Survey.

This year has brought significant change at the Board and Office. At the 2019 Fall Board Meetings in October, there were no less than 6 fresh faces. In April 2019, the CSHP Office welcomed Clara Wicke as our first Director of Marketing and Communications. After many years of dedicated service, Cathy Lyder retired as Director of Professional Practice this past fall and Christina Adams was welcomed as our first Chief Pharmacy Officer in October 2019.

One of my personal highlights of the past year was our Professional Practice Conference in February 2019. This conference marked 50 years of PPC and what a party we had to celebrate! Attendees were treated to another excellent education program. I was excited to introduce our keynote speaker, Winter Olympic champion and “Amazing Race Canada” TV show host, Jon Montgomery. Monty gave a golden motivational session and stayed around afterwards with his gold medal to pose with attendees for dozens of personal photos. The evening was capped by grand celebration (happy 50th) and tribute to Myrella Roy for her many years of service as our Executive Director. PPC is still looking good as it reaches middle age; however, big changes are coming soon for our flagship educational event. Stay tuned!

External Liaison

As External liaison, I remained occupied with rising opportunities and requests for CSHP’s input on many important issues related to hospital pharmacy practice and practitioners. CSHP has been actively contributing to the federal discussion on a national pharmacare program for many years and we welcomed the release of the report from the Advisory Council on the Implementation of National Pharmacare. Many recommendations of the Advisory Council’s report aligned with CSHP’s position statement on a national pharmacare program.

CSHP continues to enjoy a strong relationship with Health Canada. Throughout the year, I joined CSHP officers for Health Canada meetings on mandatory reporting of serious adverse drug reactions, fraudulent marketing of pharmaceuticals, and commercial compounding. We worked with the Alliance for Safe Online Pharmacies (ASOP) regarding the potential changes in US legislative framework that would allow for mass importation of drugs from Canada. Around the Midterm Board Meeting in April 2019, Jody Ciufo, Cathy Lyder, Sarah Jennings (former part-time Professional Affairs Associate 2017-2019), and I participated in a trilateral meeting with Health Canada and CPhA on various issues, such as latex content in drugs, biologics naming convention, and more. Our CSHP contingent spent the remainder of the day in Ottawa meeting with officers in the Special Access Programme, Office of Controlled Substances, and the National Association of Pharmacy Regulatory Authorities (NAPRA). Additional joint officer meetings were held during the year with Association des pharmaciens des établissements de santé du Québec (APES), Canadian Association of Pharmacy Students and Interns (CAPSI), Canadian Association of Pharmacy Technicians (CAPT), Institute for Safe Medication Practices (ISMP Canada), Pharmacy Examining Board of Canada (PEBC), and the Board of Pharmaceutical Specialties (BPS).

CSHP officers are called upon to respond to media inquiries on a variety of topics. During the year, I was interviewed on the report from the Advisory Council on the implementation of national pharmacare by the Canadian Healthcare Network; supply shortages of cancer drugs by CTV Newsnet, and the U.S. importation of Canadian medications by Radio-Canada and U.S. National Public Radio.

With the change in Canada’s legislation governing cannabis in October of 2018, CSHP heard from its members that there is a need for support and guidance in managing the clinical needs of patients who may use cannabis for medical purposes, as well as on handling cannabis products brought to hospital by patients. The CSHP Cannabis Task Force was created in the summer of 2019 with Marlys LeBras appointed as Chair in August 2019. Marlys will be moving swiftly to recruit members to the task force and begin working on its mandate.

Within the External Liaison portfolio, I am also responsible for interacting with the CSHP Advocacy Committee and numerous representatives appointed by CSHP to external committees and collaborating organizations.  I would like to briefly highlight some of their hard work over the past year:

Prescribing Safely Canada (PSC) – Royal College of Physicians and Surgeons of Canada:
CSHP Representative, Michael LeBlanc

This committee has concluded its work with the publication of “The Prescribing Safely Canada – Physician Prescribing Competencies.” The CanMEDS 2015 framework and Milestones Guide are used throughout this document for each of the ten competencies described.

Canadian National Clinical Pharmacy Key Performance Indicators (cpKPI) Collaborative:
CSHP Representative, Catherine Lyder, CSHP Director of Professional Practice

The collaborative led the creation of a national registry to collect cpKPI data. Thirty hospitals (over 240,000 patient admissions) were enrolled in a study of the registry with the data for 17 acute care hospitals (representing about 175,000 patient admissions over 12 months) subject to detailed core analysis. The results of the study are not yet publicly available. This completed the group’s 2013 vision of having (1) a suite of consensus cpKPI, (2) a knowledge mobilization kit, (3) dissemination publications/ communication, (4) patient and inter-professional feedback and (5) a national patient registry.

The collaborative was invited to speak about the topic of cpKPIs in Canadian hospitals at FIP (September 26, 2019) as part of a symposium on Global Pharmacy Quality indicators.

Catherine Lyder was an external representative to the group for many years. With her retirement from CSHP, a new representative should be appointed before the group’s November 2019 meeting.

Canadian Council for Accreditation of Pharmacy Programs (CCAPP):
CSHP Representative, Curtis Harder

Curtis Harder is our new representative to the CCAPP Board. In the past year, the title of Executive Director for CCAPP was changed to Chief Executive Officer. CCAPP made accreditation decisions for five Canadian pharmacy technician programs and one Canadian pharmacy program. Four accreditation site visits for Canadian pharmacy programs and six accreditation site visits are planned for Canadian pharmacy technician programs in 2019/2020. The CCAPP Board will be engaging in a process over the next year to re-evaluate the fees for both educational accreditation and membership to sustain growth, permit innovation, and implement new strategic actions.

Immunize Canada:
CSHP Representative, Tasha Ramsay

Tasha Ramsay is our first representative to Immunize Canada. The group’s mandate is to contribute to the control, elimination, and eradication of vaccine-preventable diseases in Canada by increasing awareness of the National Advisory Committee on Immunization’s (NACI) recommended immunizations for all ages through education, promotion, advocacy, and media relations. Plans are underway to bolster this area for CSHP members and networks by sharing Immunize Canada campaigns (influenza, pneumococcus), obtain or develop immunization-related educational resources, and consider creating position statements addressing current issues in immunization.

For a PDF copy of this report, please email: with your request.